Metrics to compare | 300791 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship300791PeersSector | |
|---|---|---|---|---|
P/E Ratio | 44.8x | 23.1x | 11.5x | |
PEG Ratio | −0.69 | 0.25 | 0.03 | |
Price/Book | 1.8x | 2.2x | 1.5x | |
Price / LTM Sales | 1.2x | 2.2x | 0.9x | |
Upside (Analyst Target) | 45.6% | 23.2% | 23.8% | |
Fair Value Upside | Unlock | 16.5% | 14.1% | Unlock |
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry China, the United States, Europe, and internationally. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; liquids; probiotic balls; tablet and powder products; capsules; and functional beverages for beauty and wellness, gut health, bone and joint health, immune and fertility support, cardiovascular and metabolic health, and healthy ageing. It also offers formulation; technical, and research and development support; and primary and final packaging services. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.